Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Interest Expenses (2022 - 2026)

Cannabis Bioscience International Holdings' Interest Expenses history spans 5 years, with the latest figure at $10776.0 for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 52.05% to $10776.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $134123.0, a 1031.99% increase, with the full-year FY2025 number at $136262.0, up 1138.75% from a year prior.
  • Interest Expenses hit $10776.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from $3230.0 in the prior quarter.
  • Over the last five years, Interest Expenses for CBIH hit a ceiling of $102749.0 in Q2 2025 and a floor of -$47904.0 in Q2 2024.
  • Historically, Interest Expenses has averaged $19325.5 across 5 years, with a median of $10776.0 in 2026.
  • Biggest five-year swings in Interest Expenses: tumbled 4072.14% in 2024 and later soared 642.54% in 2025.
  • Tracing CBIH's Interest Expenses over 5 years: stood at $36278.0 in 2022, then tumbled by 86.2% to $5005.0 in 2023, then surged by 73.85% to $8701.0 in 2024, then plummeted by 62.88% to $3230.0 in 2025, then skyrocketed by 233.62% to $10776.0 in 2026.
  • Business Quant data shows Interest Expenses for CBIH at $10776.0 in Q1 2026, $3230.0 in Q4 2025, and $17368.0 in Q3 2025.